NHS Grampian
84
13
14
40
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.8%
4 terminated/withdrawn out of 84 trials
90.9%
+4.4% vs industry average
5%
4 trials in Phase 3/4
8%
3 of 40 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (84)
Estimating Premorbid Intellectual Functioning in Children and Measuring Change in Cognitive Functioning as Children Develop
Role: collaborator
PUFFINS Brain Health Study
Role: collaborator
Neural Correlates of Autistic Individuals With Anorexia Nervosa
Role: collaborator
Health Seeking Behaviour in Women Diagnosed With Gynaecological Cancer: Can it be Modified to Improve Patient Outcomes?
Role: lead
Scottish Advanced Fetal Research Study
Role: collaborator
Point of Care Evaluation of High-sensitivity Cardiac Troponin
Role: collaborator
FCI-Glioblastoma Study
Role: collaborator
Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity
Role: collaborator
Rebalancing the Fat Content of the Heart and Muscles
Role: collaborator
Understanding the Benefits of Dietary Fibre Supplementation in Patients With Prostate Cancer
Role: collaborator
Impact of External Factors(Brexit and Covid-19) on Retention and Turnover in the NHS
Role: lead
FCI in Post-operative Low Grade Gliomas
Role: lead
Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study
Role: collaborator
FCI Effectiveness in NAFLD Stratification
Role: lead
Breast Tumour Size Measurement by Field Cycling Imaging
Role: collaborator
Feasibility of Using Surplus qFIT Samples to Investigate the Gut Microbiota.
Role: collaborator
Proving Utility of a New Field-cycling MRI Prototype in Acute Stroke Patients
Role: collaborator
The PROSECCA Study, Answering New Questions in Prostate Cancer
Role: collaborator
ICRA Randomised Controlled Trial
Role: lead
Fast Field Cycling Imaging of Kidney Disease
Role: collaborator